Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus
Clinical trial NCT01338883 · COMPLETED
Trial details
- NCT number
- NCT01338883
- Sponsor
- Tobira Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2012-12-01
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.